Bank of New Hampshire Sells 235 Shares of Danaher Co. (NYSE:DHR)

Bank of New Hampshire lowered its position in Danaher Co. (NYSE:DHR) by 3.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,533 shares of the conglomerate’s stock after selling 235 shares during the quarter. Bank of New Hampshire’s holdings in Danaher were worth $1,511,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the company. Nicholas Hoffman & Company LLC. boosted its stake in shares of Danaher by 2.3% in the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock worth $439,000 after buying an additional 43 shares during the last quarter. Drive Wealth Management LLC grew its position in shares of Danaher by 3.1% during the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock valued at $344,000 after purchasing an additional 44 shares in the last quarter. Trust Investment Advisors grew its position in Danaher by 1.8% in the fourth quarter. Trust Investment Advisors now owns 2,811 shares of the conglomerate’s stock worth $650,000 after acquiring an additional 49 shares in the last quarter. Connolly Sarah T. grew its position in Danaher by 0.5% in the third quarter. Connolly Sarah T. now owns 9,599 shares of the conglomerate’s stock worth $2,382,000 after acquiring an additional 50 shares in the last quarter. Finally, Austin Private Wealth LLC grew its position in Danaher by 3.4% in the third quarter. Austin Private Wealth LLC now owns 1,566 shares of the conglomerate’s stock worth $389,000 after acquiring an additional 51 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on DHR shares. KeyCorp upped their price objective on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, February 1st. Barclays raised their target price on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday. Bank of America increased their price target on shares of Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a report on Wednesday. Citigroup raised their target price on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and raised their target price for the stock from $250.00 to $280.00 in a report on Wednesday, April 17th. Six analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $270.00.

Danaher Stock Performance

NYSE:DHR traded up $2.16 during trading hours on Friday, hitting $247.96. 1,401,300 shares of the company were exchanged, compared to its average volume of 2,769,207. The company’s 50 day moving average price is $248.94 and its 200-day moving average price is $230.88. The stock has a market capitalization of $183.66 billion, a price-to-earnings ratio of 41.66, a PEG ratio of 4.19 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.37. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $259.00.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. During the same period in the prior year, the firm earned $2.36 EPS. The business’s revenue for the quarter was down 2.6% on a year-over-year basis. As a group, research analysts forecast that Danaher Co. will post 7.64 earnings per share for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio is 18.31%.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 4,000 shares of the stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the sale, the senior vice president now directly owns 29,830 shares of the company’s stock, valued at $7,457,798.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Danaher news, SVP Brian W. Ellis sold 4,000 shares of the company’s stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the completion of the transaction, the senior vice president now directly owns 29,830 shares in the company, valued at $7,457,798.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Rainer Blair sold 47,175 shares of the company’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the transaction, the chief executive officer now owns 115,995 shares of the company’s stock, valued at $28,908,273.90. The disclosure for this sale can be found here. Over the last three months, insiders have sold 84,132 shares of company stock valued at $21,022,795. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.